National Institute on Aging (NIA)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute on Aging (NIA) sits in the top decile of US sponsors by registered trial count (#209 of 15,742 sponsors by registered trial count).
National Institute on Aging (NIA): 131 sponsored US clinical trials, 12 recruiting.
National Institute on Aging (NIA) sponsors 131 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 103 completed. 18 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 7 trials.
Top-decile sponsor footprint
National Institute on Aging (NIA) ranks in the top decile of sponsors by registered trial count (#209 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
103 of 116 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
131 total, page 3 of 3
Osteoarthritis: Weakness From Inflammation
NCT00104312
PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
NCT00239694
SeniorWISE: Improving Everyday Memory in At-Risk Elderly
NCT00094731
BVAIT: B-Vitamin Atherosclerosis Intervention Trial
NCT00114400
PACT: Providers and Alzheimer's Caregivers Together
NCT00182897
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163
Biological Effects of Dehydroepiandrosterone (DHEA) in the Elderly
NCT00111930
Exercise for Elderly Peripheral Revascularized Patients
NCT00667290
Alternative Therapies for Menopause: A Randomized Trial
NCT00061711
A Trial to Reduce Delirium in Aged Post Acute Patients
NCT00182936
Obesity Prevention After Smoking Cessation in Menopause
NCT00064961
AFTER: Altering Fat Through Estrogen and Raloxifene
NCT00149604
A Trial of Tap Water Treatment in the Elderly
NCT00058942
Homeostatic Sleep Regulation in Older Persons
NCT00601445
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00003993
The CHAT (Community Health Advice by Telephone) Study
NCT00131092
Memory Impairment Study (Mild Cognitive Impairment Study)
NCT00000173
Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
NCT00099567
VEAPS: Vitamin E Atherosclerosis Prevention Study
NCT00114387
Estrogen Hormone Protocol
NCT00000177
EPAT: Estrogen in the Prevention of Atherosclerosis Trial
NCT00115024
Exercise Rehabilitation of Younger and Older People With Claudication
NCT00654810
A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
NCT00004845
Multicenter Trial of Prednisone in Alzheimer's Disease
NCT00000178
Study of Melatonin: Sleep Problems in Alzheimer's Disease
NCT00000171
Alzheimer's Disease Prevention Trial
NCT00000176
AIT-082 Phase 1B Study
NCT00000180
Agitation in Alzheimer's Disease
NCT00000179
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
NCT00013923
Healthy Aging and Memory Study
NCT00034567
The Effects of Sex Hormones on Cognition and Mood in Older Adults
NCT00000175
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 18 |
| Phase 2 | 20 |
| Phase 3 | 14 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the National Institute on Aging (NIA) pipeline
12 recruiting of 131 indexed (9% open); 103 completed (79%).
Phase mix: 18 late (III/IV) vs 38 early (I/II) (early-phase heavy).
Top condition: Aging (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute on Aging (NIA): open-pipeline peers nationwide
Peers matched on 131 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
National Institute on Aging (NIA) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 131 trials (± recruiting share)
- Rhode Island Hospital · 130 trials · 20% recruiting
- George Washington University · 133 trials · 18% recruiting
- University of Illinois at Urbana-Champaign · 129 trials · 14% recruiting
- Jazz Pharmaceuticals · 128 trials · 12% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Alkermes · 9% recruiting · 66 trials
- DBV Technologies · 9% recruiting · 11 trials
- Florida Gulf Coast University · 9% recruiting · 11 trials
- Genfit · 9% recruiting · 11 trials
Related
What to do with this National Institute on Aging (NIA) page
131 registered trials is a research-attention snapshot, not an endorsement of National Institute on Aging (NIA) or any single study.
- 12 of National Institute on Aging (NIA)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aging is the condition National Institute on Aging (NIA) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Institute on Aging (NIA) pipeline card: 131 registered trials from official public datasets.Report a data error.